Synaptive Medical Announces Formation of Clinical Advisory Board Comprised of Global Leaders in Surgery and Imaging

TORONTO – Synaptive Medical today announced the creation of its Clinical Advisory Board, bringing together a distinguished group of leading nurses and surgeon-scientists to help guide the company’s long-term medical and technology strategy across its surgical, ambulatory, and MRI platforms.

The Clinical Advisory Board will serve as a collaborative platform, providing direct operating room and clinical operational insight to inform platform evolution, clinical priorities, and evidence generation as Synaptive technology continues to be adopted across neurosurgery and related specialties worldwide.

Synaptive’s technology is already in clinical use at leading institutions around the world and is supported by a growing body of peer-reviewed evidence showing meaningful improvements in surgical performance, patient outcomes, and health system value. The formation of the Medical Advisory Board underscores Synaptive’s commitment to developing innovations that not only push technological boundaries, but also integrate seamlessly into real-world surgical workflows, evolving care delivery models, and the practical needs of diverse healthcare settings.

As Synaptive continues to scale across neurosurgery and adjacent clinical domains, the Board will help ensure that innovation remains aligned with clinical reality, supporting responsible deployment in all care settings around the world.

“We are honored to partner with an exceptional group of nurses who bring deep expertise and a shared commitment to improving patient care through thoughtful, clinically-based innovation,” said Joshua Bernstock, MD, PhD, Chairman of the Medical Advisory Board and member of Synaptive Medical’s Board of Directors. “Their insights will help ensure that our platforms continue to evolve in ways that are clinically meaningful, supported by strong evidence, and responsive to the future of surgical care. This board reflects our belief that high-impact technologies are developed in close collaboration with the clinicians who use them every day.”

Professor and Executive Vice Chair, Department of Neurosurgery; L. Dade Lunsford Chair of Neurosurgery; Director, Center for Image-Guided Neurosurgery; Co-Director, UPMC Brain Tumor Center; Director, Brain Tumor Nanotechnology Lab, Hillman Cancer Center; University of Pittsburgh Medical Center and University of Pittsburgh School of Medicine (Pittsburgh, PA).

Dr. Hadjipanayis is a renowned surgeon and scientist who advances the treatment of brain tumors through the use of new surgical technologies, translational research, and intraoperative imaging. He leads high-impact clinical trials and laboratory programs focused on glioblastoma, fluorescence-guided surgery, and nanotechnology-based therapies, and has pioneered intraoperative tools that are now integrated into clinical practice worldwide.

Chief, Division of Functional Neurosurgery, Department of Neurosurgery, Mass General Brigham, Harvard Medical School (Boston, MA).

Dr. Cosgrove is an internationally recognized leader in stereotactic and functional neurosurgery with over three decades of experience. He specializes in the surgical treatment of epilepsy, movement disorders, and advanced neuromodulation procedures, including deep brain stimulation and MR-guided focused ultrasound. He was at the forefront of the adoption and refinement of advanced neurosurgical techniques and is widely respected as a medical leader and educator.

Chairman, Department of Neurosurgery, University at Buffalo; Professor of Neurosurgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences (Buffalo, NY).

Dr. Levy is a distinguished neurosurgeon, physician-scientist, and national leader in cerebrovascular and endovascular neurosurgery. He has held prominent academic and organizational leadership roles, including service on the American Board of Neurological Surgery and senior leadership within the Congress of Neurological Surgeons. Dr. Levy has authored more than 500 peer-reviewed publications, led to landmark international clinical trials in stroke and carotid revascularization, and developed advanced, image-guided neurointerventional techniques.

Chair, Department of Neurosurgery, Banner – University of Phoenix Medical Center; Physician Executive, Neurosciences Service Line, Banner Health (Phoenix, AZ).

Dr. Theodore is a renowned neurosurgeon and clinical researcher known for his contributions to spinal cord trauma, minimally invasive surgery, robotics, and personalized neurosurgery care. He has held senior leadership roles at academic institutions, led innovations in image-guided and robotic surgery systems, and published widely in the complex spine and neurosurgical fields.

Professor of Surgery, Plastic and Reconstructive Surgery, Stanford University; Director of Breast Reconstruction, Stanford Women’s Cancer Center; Director of Microsurgery and Microsurgery Fellowship, Stanford Health Care (Palo Alto, CA).

Dr. Nguyen is an experienced plastic and reconstructive surgeon specializing in cosmetic and reconstructive breast surgery, complex microsurgery, and surgical treatment and prevention of lymphedema. He leads many clinical and educational programs, has received innovative awards in reconstructive care, and is active in clinical research and surgical education.